数字药房市场：按药物类型（非处方药、处方药）、平台（应用程序、网站）划分 - 全球预测 2023-2030 年

全球数字药房市场预计到 2023 年将大幅增长，达到 1389.1 亿美元，年复合成长率为 19.13%，预计到 2030 年将达到惊人的 4750.8 亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球数字药房市场至关重要。通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的资讯。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 全球数字药店市场规模及预测是多少？

2. 在预测期内，COVID-19 对全球数字药房市场的抑制要素和影响有哪些？

3. 在预测期内，全球数字药房市场需要投资哪些产品/细分市场/应用/领域？

4、全球数字药房市场的竞争策略是什么？

5. 全球数字药房市场的技术趋势和法律规范是什么？

6、全球数字药房市场主要厂商的市场份额是多少？

7. 数字药房进入全球市场的型态和战略倡议被认为是合适的？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 消费者越来越偏好在线购买药品
    • 政府加大数字化力度
    • 需要监控数字疗法和患者特定资料的可用性不断增加
  • 抑制因素
    • 患者依赖线下药师提供临床支持
  • 机会
    • 扩大远端医疗和远端医疗的采用
    • 智能镜子技术与家庭健康筛查工具的整合和嵌入
  • 任务
    • 对安全和非法网上药店存在的担忧
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通胀的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户定制

第6章按药物类型分類的数字药房市场

• 非处方药物
• 处方药

第7章数字药房市场：按平台

• 应用程式
• 网站

第8章美洲数字药房市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第9章亚太数字药房市场

• 澳大利亚
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第10章欧洲、中东和非洲的数字药房市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第11章竞争形势

• FPNV定位矩阵
• 市场份额分析：主要企业
• 竞争情景分析：主要企业

第12章上市公司名单

第13章附录

• 讨论指南
• 关于许可和定价

The Global Digital Pharmacy Market is forecasted to grow significantly, with a projected USD 138.91 billion in 2023 at a CAGR of 19.13% and expected to reach a staggering USD 475.08 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Digital Pharmacy Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Digital Pharmacy Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Type, market is studied across Over-The-Counter Drugs and Prescription Drugs. The Over-The-Counter Drugs is projected to witness significant market share during forecast period.

Based on Platform, market is studied across Apps and Websites. The Apps is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Digital Pharmacy Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Digital Pharmacy Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital Pharmacy Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital Pharmacy Market?

4. What is the competitive strategic window for opportunities in the Global Digital Pharmacy Market?

5. What are the technology trends and regulatory frameworks in the Global Digital Pharmacy Market?

6. What is the market share of the leading vendors in the Global Digital Pharmacy Market?

7. What modes and strategic moves are considered suitable for entering the Global Digital Pharmacy Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Digital Pharmacy Market, by Drug Type, 2022 vs 2030
• 4.3. Digital Pharmacy Market, by Platform, 2022 vs 2030
• 4.4. Digital Pharmacy Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing consumer preference towards buying medicines online
    • 5.1.1.2. Rising government initiatives towards digitalization
    • 5.1.1.3. Need to monitor growing availability of digital therapeutics and patient-specific data
  • 5.1.2. Restraints
    • 5.1.2.1. Patients reliance on offline pharmacists for clinical support
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adoption of telehealth and telemedicine
    • 5.1.3.2. Integration and incorporation of smart mirrors technology and home health diagnostic tools
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to security and presence of illegal online pharmacies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Digital Pharmacy Market, by Drug Type

• 6.1. Introduction
• 6.2. Over-The-Counter Drugs
• 6.3. Prescription Drugs

7. Digital Pharmacy Market, by Platform

• 7.1. Introduction
• 7.2. Apps
• 7.3. Websites

8. Americas Digital Pharmacy Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Digital Pharmacy Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Digital Pharmacy Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. DIGITAL PHARMACY MARKET RESEARCH PROCESS
• FIGURE 2. DIGITAL PHARMACY MARKET SIZE, 2022 VS 2030
• FIGURE 3. DIGITAL PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
• FIGURE 5. DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2022 VS 2030 (%)
• FIGURE 6. DIGITAL PHARMACY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 7. DIGITAL PHARMACY MARKET DYNAMICS
• FIGURE 8. DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 9. DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. DIGITAL PHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 15. DIGITAL PHARMACY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. DIGITAL PHARMACY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. DIGITAL PHARMACY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 5. DIGITAL PHARMACY MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. DIGITAL PHARMACY MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 8. DIGITAL PHARMACY MARKET SIZE, BY APPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. DIGITAL PHARMACY MARKET SIZE, BY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 11. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 12. AMERICAS DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 13. ARGENTINA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 14. ARGENTINA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 15. BRAZIL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 16. BRAZIL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 17. CANADA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 18. CANADA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 19. MEXICO DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 20. MEXICO DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 21. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 22. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 23. UNITED STATES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 24. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ASIA-PACIFIC DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 27. AUSTRALIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AUSTRALIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 29. CHINA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CHINA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 31. INDIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 32. INDIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 33. INDONESIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 34. INDONESIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 35. JAPAN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 36. JAPAN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 37. MALAYSIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MALAYSIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 39. PHILIPPINES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 40. PHILIPPINES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 41. SINGAPORE DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 42. SINGAPORE DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 43. SOUTH KOREA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 44. SOUTH KOREA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 45. TAIWAN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 46. TAIWAN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 47. THAILAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 48. THAILAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 49. VIETNAM DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 50. VIETNAM DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 51. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 53. EUROPE, MIDDLE EAST & AFRICA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 54. DENMARK DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 55. DENMARK DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 56. EGYPT DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EGYPT DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 58. FINLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 59. FINLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 60. FRANCE DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 61. FRANCE DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 62. GERMANY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 63. GERMANY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 64. ISRAEL DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 65. ISRAEL DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 66. ITALY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ITALY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 68. NETHERLANDS DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 69. NETHERLANDS DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 70. NIGERIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 71. NIGERIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 72. NORWAY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NORWAY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 74. POLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 75. POLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 76. QATAR DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 77. QATAR DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 78. RUSSIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 79. RUSSIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 80. SAUDI ARABIA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 81. SAUDI ARABIA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH AFRICA DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH AFRICA DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 84. SPAIN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SPAIN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 86. SWEDEN DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SWEDEN DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 88. SWITZERLAND DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SWITZERLAND DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 90. TURKEY DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TURKEY DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 92. UNITED ARAB EMIRATES DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 93. UNITED ARAB EMIRATES DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 94. UNITED KINGDOM DIGITAL PHARMACY MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED KINGDOM DIGITAL PHARMACY MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 96. DIGITAL PHARMACY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 97. DIGITAL PHARMACY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 98. DIGITAL PHARMACY MARKET LICENSE & PRICING